Healio Minute

This week, a speaker predicts the AMD epidemic will continue to challenge ophthalmologists; pegcetacoplan results in 18-month reduction in GA lesion growth; interim trial results show efficacy of photo-bio-modulation in dry AMD; and more.

Read the full coverage here:

AMD epidemic will continue to challenge ophthalmologists

Reduction in GA lesion growth continues at 18 months with pegcetacoplan

Interim trial results show efficacy of photobiomodulation in dry AMD

Ophthalmological manifestations observed in one-third of COVID-19 cases at single center

PDT may be effective for choroidal metastasis treatment

References:

Chew EY. Irving H. Leopold Lecture: Age-related macular degeneration: What have we learned from the age-related eye disease study (AREDS) and AREDS2? Presented at: Wills Eye Conference; March 10-12, 2022; Philadelphia.

Press Release

Press Release

Romero-Castro RM, et al. Retina. 2022;doi:10.1097/IAE.0000000000003457.

Sacconi R, et al. Retina. 2022;doi:10.1097/IAE.0000000000003305.

In this week's addition, the FDA approval of a transdermal patch to treat Alzheimer's-related dementia; the link between daily napping among older adults and an increased risk for Alzheimer's disease; an oral treatment for Parkinson's demonstrated positive phase 2 results; and more.

Read the full coverage here:

FDA approves transdermal patch to treat Alzheimer's-related dementia

Daily napping among older adults linked to a 40% higher risk for Alzheimer's disease

Oral treatment for Parkinson's shows positive phase 2 results

Sleep academy warns lawmakers about health risks of permanent daylight saving time

AAN: Medication, exercise more beneficial than stent in preventing stroke

References:

Press Release

Li P, et al. Alzheimers Dement. 2022;doi:10.1002/alz.12636.

Press Release

Press Release

Turan TN, et al. Neurology. 2022;doi:10.1212/WNL.0000000000200030.